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Abstract 
Background: The Alberta Stroke Program Early CT score (ASPECTS) is an established 10-
point quantitative topographic CT scan score to assess early ischemic changes. We 
performed a non-inferiority trial between the e-ASPECTS software and neuroradiologists 
(NRAD) in scoring ASPECTS on non-contrast enhanced CT images (NCCT) of acute ischemic 
stroke patients. 
Methods: In this multicentre study, e-ASPECTS and three independent NRADs 
retrospectively and blindly assessed baseline NCCTs of 132 patients with acute anterior 
circulation ischemic stroke. Follow-up scans served as ground truth to determine the 
definite area of infarction.  Sensitivity, specificity and accuracy (SSA) for region based and 
score based analysis, ROC curves, Bland-Altman plots and Matthews correlation 
coefficients (MCC) relative to the ground truth were calculated and comparisons were made 
between NRADs and different pre-specified e-ASPECTS operating points. The non-
inferiority margin was set to 10% for both sensitivity and specificity on region based 
analysis. 
Results: In total 2640 (132 patients x 20 regions per patient) ASPECTS regions were 
scored. Mean time from onset to baseline CT was 146+/-124 min and median NIHSS was 
11 (6-17, IQR). Median ASPECTS for ground truth on follow-up imaging was 8 (6.5-9, IQR). 
In the region based analysis, two e-ASPECTS operating points (SSA of 44%, 93%, 87% 
and 44%, 91%, 85%) were statistically non-inferior to all three NRADs (all p-values 
<0.003). Both MCCs for e-ASPECTS were higher (0.36 and 0.34) than those of all NRADs 
(0.32. 0.31 and 0.3). 
Conclusions: e-ASPECTS was non-inferior to three neuroradiologists in scoring ASPECTS 
on NCCTs of acute stroke patients. 
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Introduction 
 
The Alberta Stroke Program Early CT Score (ASPECTS) is a topographic scoring system for 
acute ischemic damage to brain that divides the middle cerebral artery (MCA) territory into 
10 areas of interest (1). It has recently been used for the enrolment of patients in 
endovascular treatment trials, in which only patients with an ASPECTS of 6 or 7 and above 
could be included (2-4). However, the interpretation of the ASPECTS on a non-contrast 
enhanced computer tomography (NCCT) brain scan of patients with an acute ischemic 
stroke is challenging and variable, even between stroke experts (5, 6). Therefore, 
standardized and automated assessment of ischemic damage would be useful in clinical 
practice and research. A proof-of-concept study showed that machine learning methods 
applied to acute stroke NCCT images offered an improved prediction of symptomatic 
intracerebral hemorrhage over common prognostic clinical scores (7). The e-ASPECTS 
software is a commercially available, now CE-marked, standardized and fully automated 
ASPECTS scoring tool based on a machine learning algorithm (8). Recently, it was shown 
that e-ASPECTS was more sensitive in detecting early signs of cerebral ischemia than junior 
stroke physicians, who are usually the first interpreters of a scan of an acute stroke patient. 
Although the software performed similar to stroke experts, it was not powered to claim 
non-inferiority (9). In this non-inferiority trial with NCCTs of acute ischemic stroke patients 
from five different stroke centres, we compared the scoring performance of e-ASPECTS 
with those of three independent neuroradiologists (NRADs), experienced in diagnosing 
early ischemic damage. 
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Methods 
 
Patients  
Patients with acute ischemic stroke syndromes in the anterior circulation, as clinically 
determined, and available baseline and follow-up NCCTs, obtained between 24 and 36 
hours after baseline imaging, were eligible. Patients with haemorrhage or severe imaging 
artefacts on baseline imaging or when consent could not be obtained in accordance with 
the national procedures stipulated by the respective ethics commissions, were excluded.  
The Norfolk NRES Committee East of England and Freiburg ethics committee approved the 
study. All patients were treated according to local in house protocols on the respective local 
stroke units. For further details on participating centers and CT scanner details please see 
the suppl. Material. 
 
 
e-ASPECTS and ASPECTS scoring of NRADs 
The ASPECTS score of the ground truth was determined by an independent core lab 
(Medical Imaging Heidelberg GmbH, Heidelberg, Germany) and based on both the initial 
imaging as well as on the follow up imaging; i.e. only lesions that were present on baseline 
imaging and follow-up were scored. e-ASPECTS was run on an Intel ® Core i7 processor. 
Following pre-processing of the DICOM input images, a registration step corrects for any 
3D rotation and tilt. Image features are then extracted and scored with a machine learning 
classifier to identify early ischemic signs (suppl. Material and 8,9). Pseudonymized baseline 
NCCT were retrospectively scored by eight different pre-specified e-ASPECTS operating 
points (OP) as well as by three NRADs (PP, JH and AAK who were not affiliated with the 
participating clinical sites). Each NRAD had over 10 years’ clinical experience in acute 
stroke imaging and interventional neuroradiology. The e-ASPECTS OPs reflect settings, 
which essentially determine how much weight is given to misclassifications in the “true 
positive (damage)” score versus the “true negative (no damage)” score of the algorithm – 
i.e. modulating sensitivity and specificity and simulating different physicians’ behaviour. e-
ASPECTS and the human scorers were blinded for any clinical information except that a 
unilateral ischemic stroke in the anterior circulation was suspected.  
 
Data analysis 
Prior to conduction of the study, a sample size calculation was carried out based on the 
methods of Ying Lu et al. (10) for simultaneous comparison of sensitivity and specificity 
(suppl. material). The non-inferiority margin was set to 10% for both sensitivity and 
specificity, based on our previous clinical experience (suppl. material).  This calculation 
yielded 128 necessary patients, i.e. 2560 ASPECTS regions for a region based analysis (see 
below).  
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Sensitivity and specificity as well as accuracy based on true positive (TP), true negative 
(TN), false positives (FP) and false negative (FN) scores were calculated individually over 
all ASPECTS regions and for the overall ASPECTS score for each e-ASPECTS OP and each 
NRAD. Since the results were expected to be correlated within patients, two methods for 
clustered data were used to estimate sensitivity and specificity (and 95% confidence 
intervals):  variance adjustment using a sandwich estimator and generalized estimating 
equations (GEE) (11). In the GEE approach, the estimated sensitivity (and specificity) is 
interpreted as the weighted average across the study population (“population averaged”). 
This approach hence delivers the mean sensitivity and specificity across all patient-specific 
estimates of sensitivity (and specificity).  
 
Receiver-operating characteristic (ROC) curves were generated for three analysis methods, 
for the region-based analysis (20*132 regions), the score-based analysis (10 points) and 
for the dichotomized ASPECTS score of >5 (suppl. material).  
 
Sensitivities and specificities of the region-based analysis were then compared between 
each e-ASPECTS OP and each NRAD. The non-inferiority (one-sided) statistical test was 
calculated based on Lu et al (10). The 95% confidence intervals for the difference between 
e-ASPECTS and scorers are based on the Adjusted Wald Method (12). As a sensitivity 
analysis, differences and 95% confidence intervals were also calculated using GEE to take 
account of potential correlations within patients. For each given couple of e-ASPECTS OP 
and scorers, if the lower 95% confidence interval boundary for the difference of e-ASPECTS 
minus score does not cross -10% (the non-inferiority margin) for both sensitivity and 
specificity, then non-inferiority can be concluded; furthermore if in addition the upper 
boundary for the confidence interval of the difference does not cross +10%, then 
equivalence can be concluded.  
 
Matthews correlation coefficients (MCC) which range between [-1;1]  (0 = random 
prediction) were also calculated. The MCC summarises in a single value the performance 
in damage detection in the unbalanced dataset since there are a large number of true 
negative from the 10 contra-lateral regions for each case. Additionally, Bland-Altman plots 
and histograms were generated for e-ASPECTS OP#4 and grouped for all NRADs in order 
to illustrate the distribution of the error in ASPECTS score.  
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Results 
 
In total 134 patients who met the inclusion criteria were identified.  Two patients had to 
be excluded because the core lab deemed CT imaging artifacts impaired image analyses 
by NRADs and e-ASPECTS. Finally, 132 patients were included in the study and 2640 
ASPECTS regions were analysed. Median age of the patients was 72 years (63-79, IQR) 
and 55% were male. Mean time from onset to baseline CT was 146+/-124 min and median 
NIHSS was 11 (6-17, IQR). Three patients were treated with an endovascular approach 
and 123 patients were treated with intravenous thrombolysis.  Median ASPECTS for the 
ground truth on follow up imaging was 8 (6-9 IQR, Suppl. Figure). 
 
All relevant scoring data, including true positive (TP), true negative (TN), false positive 
(FP) and false negative (FN) scores as well as respective sensitivity, specificity (with 
confidence intervals for both methods) and accuracy for all e-ASPECTS OPs and all NRADs 
in the region based analysis are displayed in table 1.  
 
Importantly, the results for the two analysis methods show no relevant difference.  
Sensitivity, specificity and accuracy were as follows for the human scorers: NRAD1 - 45%, 
89% and 84%, NRAD2 – 27%, 96%, 88% and NRAD3 – 26%, 97% and 89%, respectively. 
For the three NRADs, sensitivity and specificity are also illustrated (triangles) in the ROC 
space on the Figure 1A.   
 
Two e-ASPECTS OPs (#4 and#5) were statistically non-inferior to all three NRADs (all p-
values <0.003; 44%, 93%, 87% and 45%, 91%, 85% respectively for e-ASPECTS OP#4 
and OP#5). The difference between e-ASPECTS (OP#4 and #5) and NRADs is summarised 
in table 2 together with the p-values for the non-inferiority test.  
 
In summary, both OPs were shown to be non-inferior to all NRADs (except for the GEE 
analysis of OP#4 and OP#5 vs. NRAD1) for sensitivity and specificity; both OPs were 
equivalent to NRAD1 (except for GEE analysis for OP#4 and OP#5), for the other 
comparisons the OPs were equivalent for specificity and superior for sensitivity. 
 
These two e-ASPECTS OPs are also indicated in Figure 1. Two ROC curves illustrate the 
performance of e-ASPECTS against the human scorers, i.e. Figure 1B which is illustrating 
performance parameters in the score based analysis and Figure 1C which is illustrating 
sensitivity and specificity in the ROC space for a dichotomized analysis of ASPECTS>5. 
Importantly, e-ASPECTS OP#4 identified 97% of patients with an ASPECTS>5 correctly.  
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For further comparison of e-ASPECTS OP#4 and the manual ASPECTS of all NRAD with the 
ground truth, Bland-Altman plots and histograms of score difference or score error were 
generated. In Figure 2, the Bland-Altman graph displays a scatter diagram of the 
differences between the ASPECTS score and ground truth plotted against the averages of 
the three scores. This graph allows to visually assess a possible absolute systematic error, 
respectively the mean error in scoring as compared to the ground truth. 
 
Finally, the Matthews correlation coefficient (MCC), used as a measure of binary 
classification accuracy, were best (0.36 and 0.34) for e-ASPECTS OP#4 and #5, 
respectively, thereby showing better prediction of the ground truth by e-ASPECTS (table 
1). 
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Discussion 
 
This is the first trial to demonstrate equivalent specificity and non-inferior or even superior 
sensitivity of the e-ASPECTS software compared to ASPECTS scoring by experienced 
neuroradiologists (with specific expertise in acute stroke imaging) of baseline NCCTs from 
acute ischemic stroke patients. A previous monocentric proof-of concept study already 
demonstrated superiority of e-ASPECTS to stroke trainees regarding sensitivity of a region 
based analysis approach (9).  
In our multicentre, multiscanner study two different operating points (i.e. OP#4 and OP#5) 
of e-ASPECTS proved to be statistically non-inferior and equivalent to all three NRADs. 
Complementary analysis by Bland-Altman plots and MCCs confirmed the equal 
performance of the software and the human scorers when compared to the ground truth 
(Figures 1&2). 
In the past months, endovascular stroke therapy of the anterior circulation has been 
labelled as the “new standard of care” for patients with large vessel occlusion (13). 
Recently, a systematic meta-analysis with 2423 patients supported this enthusiasm 
through an increased odds ratio of 2.23 for favourable functional outcome (as compared 
to best medical treatment) when newer generation thrombectomy devices were employed 
in more than 50% of cases (14). Importantly, the vast majority of patients in these trials 
were treated based on CT imaging. Selection of the appropriate patient for acute 
recanalization therapy, i.e. thrombolysis and endovascular treatment is an important 
process in each acute stroke service or referring hospital, that needs to happen rapidly. 
Next to the clinical information, i.e. age, time window, concomitant diseases, etc., 
information from imaging is essential to distinguish between patients likely to benefit and 
those with a high probability of futile treatment. While the ASPECTS score has previously 
been shown to be a strong predictor of functional outcome following thrombolytic treatment 
(1), it has now prospectively and successfully been demonstrated that it also predicts 
outcome after endovascular treatment. Importantly, the above mentioned, independent 
meta-analysis showed that both ASPECTS subgroups, 8-10 (minimal ischemic damage) 
and 5-7 (moderate ischemic damage) on baseline CT imaging were significantly associated 
with improved outcome (OR 2.1 and 2.04, respectively for mRS 0-2 against best medical 
treatment) (14). Patients with a low ASPECTS of 0-4 showed no treatment benefit, 
although it needs to be mentioned that this analysis was only based on 28 patients of the 
MR-CLEAN trial. The recent ESO-Karolinska “consensus statement on mechanical 
thrombectomy in acute ischemic stroke” suggests that patients with radiological signs of 
large infarcts may be unsuitable for thrombectomy and proposes using the ASPECTS (15). 
Moreover, The Stroke Imaging Research (STIR) group very recently recommended in a 
consensus statement to use ASPECTS on NCCT in order to determine infarct core size and 
to focus research on standardizing imaging and on image reconstruction algorithms (16).  
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J.C. Grotta and W. Hacke, after publication of the thrombectomy trials, pointed out that 
resources for endovascular treatment are still scarce and that community hospitals swiftly 
need to establish diagnostic and selection algorithms as well as communication and 
transportation pathways for eligible patients (17). In this setting, e-ASPECTS might be a 
valuable tool especially for those referring hospitals, since expert assessment of NCCT 
imaging or even advanced perfusion CT imaging is rarely available 24/7.  
The strengths of this study are the multicentric design, which meant that NCCTs were 
acquired with various CT scanners indicating generalisation of the results. A limitation is 
surely that the ground truth was based on the assessment of both the baseline and the 
follow up CT scan by the core imaging lab and not on expeditious MRI or perfusion CT 
imaging; however that should not hamper the overall comparison between human NRAD 
scorers and e-ASPECTS, as any potential bias would affect equally human NRAD scorers 
and e-ASPECTS. Although e-ASPECTS is CE-marked, careful assessment of each CT scan 
by the physician to rule out other pathologies and haemorrhage is still mandatory. It is not 
intended to replace the physician’s assessment of the scan but it can be a valuable second 
opinion and confirmation of the own interpretation on expert level. 
 
Conclusions 
 
In this multicentre trial with 132 patients, e-ASPECTS was shown to be non-inferior to 
experienced neuroradiologists in applying the ASPECTS score to NCCTs of acute ischemic 
stroke patients.   
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Figure 1: Receiver-operating characteristic (ROC) curves for e-ASPECTS and performance 
of NRADs. (A). ROC curve for ASPECTS on region-based analysis (20 regions) for e-
ASPECTS (red dashed line) and performance of NRADs (up-pointing blue triangles). (B). 
ROC curve for ASPECTS score-based analysis for e-ASPECTS (red dashed line) and 
performance of NRADs. (C). ROC curve associated to eligibility for endovascular treatment 
(ASPECTS>5) as determined by e-ASPECTS (red dashed line) and classification by NRADs 
(blue). OP#4: operating point for e-ASPECTS. Grey dashed diagonals represent the line of 
no-discrimination associated to random guess. 
 
Figure 2: Bland-Altman plots and associated histograms of score error. Bland-
Altman plots (left panel) with mean score error (grey dashed line) and histograms (right 
panel) of score error for e-ASPECTS (OP#4) (A) and NRADs (B)  
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Table 1: Region-based scoring results of e-ASPECTS and the three NRADs. Sensitivities, 
specificities, accuracies and Matthews correlation coefficient (MCC) are given for all scorers 
and e-ASPECTS operating points (Fig. 1). Values are given for all regions and for the set 
of 4 regions at the ganglionic level (L, I, C, IC) and for the set of 6 cortical regions M1-M6. 
 
 
e-
ASPECTS 
#1 
e-
ASPECTS 
#2 
e-
ASPECTS 
#3 
e-
ASPECTS 
#4 
e-
ASPECTS 
#5 
e-
ASPECTS 
#6 
e-
ASPECTS 
#7 
e-
ASPECTS 
#8 NRAD #1 NRAD #2 NRAD #3 
TP  66 73 89 132 137 158 179 192 137 81 79 
TN  2269 2246 2226 2163 2119 2053 1916 1820 2073 2254 2267 
FP  68 91 111 174 218 284 421 517 264 83 70 
FN  237 230 214 171 166 145 124 111 166 222 224 
Sensitivity  
(all regions) 
21.78 % 
(15.7, 
27.8) 
 24.09 % 
(18.2, 
30.0) 
 29.37 % 
(23.3, 
35.4) 
 43.56 % 
(37.0, 50.1) 
 45.21 % 
(38.8, 
51.7) 
 52.15 % 
(45.5, 
58.8) 
 59.08 % 
(52.6, 
65.5) 
 63.37 % 
(56.6, 
70.2) 
 45.21 % 
(38.0, 
52.4) 
 26.73 % 
(20.9, 32.6) 
 26.07 % 
(20.5, 31.7) 
Specificity  
(all regions) 
97.09 % 
(96.2, 
98.0) 
 96.11 % 
(95.2, 
97.0) 
 95.25 % 
(94.2, 
96.3) 
 92.55 % 
(91.3, 93.8) 
 90.67 % 
(89.3, 
92.1) 
 87.85 % 
(86.4, 
89.3) 
 81.99 % 
(80.4, 
83.5) 
 77.88 % 
(76.3, 
79.4) 
 88.70 % 
(87.1, 
90.3) 
 96.45 % 
(95.3, 97.6) 
 97.00 % 
(95.9, 98.1) 
Sensitivity 
GEE 
20.79 % 
(15.0, 
26.6) 
23.21 % 
(17.5, 
28.9) 
28.59 % 
(22.6, 
34.6) 
42.01 % 
(35.5, 48.5) 
43.93 % 
(37.4, 
50.5) 
50.32 % 
(43.6, 
57.1) 
57.04 % 
(50.4, 
63.7) 
60.85 % 
(53.8, 
67.9) 
44.02 % 
(36.7, 
51.3) 
25.70 % 
(19.9, 31.5) 
25.46 % 
(20.0, 31.0) 
Specificity 
GEE 
97.05 % 
(96.2, 
97.9) 
96.08 % 
(95.1, 
97.0) 
95.22 % 
(94.2, 
96.3) 
92.53 % 
(91.3, 93.8) 
90.67 % 
(89.3, 
92.1) 
87.8 % 
(86.4, 
89.3) 
81.99 % 
(80.4, 
83.5) 
77.85 % 
(76.3, 
79.4) 
88.72 % 
(87.2, 
90.3) 
96.41 % 
(96.3, 97.5) 
96.92 % 
(95.8, 98.0) 
Accuracy  
(all regions) 88.45 %  87.84 %  87.69 %  86.93 %  85.45 %  83.75 %  79.36 %  76.21 %  83.71 %  88.45 %  88.86 % 
Sensitivity  
(L, I, C, IC) 27.54 %  29.71 %  37.68 %  44.93 %  44.93 %  47.83 %  50.00 %  53.62 %  51.45 %  41.30 %  37.68 % 
Specificity  
(L, I, C, IC) 95.21 %  93.68 %  92.59 %  89.76 %  89.87 %  87.58 %  82.24 %  80.94 %  86.60 %  94.01 %  95.21 % 
Accuracy 
 (L, I, C, IC) 86.36 %  85.32 %  85.42 %  83.90 %  84.00 %  82.39 %  78.03 %  77.37 %  82.01 %  87.12 %  87.69 % 
Sensitivity  
(M1-6) 16.97 %  19.39 %  22.42 %  42.42 %  45.45 %  55.76 %  66.67 %  71.52 %  40.00 %  14.55 %  16.36 % 
Specificity  
(M1-6) 98.31 %  97.67 %  96.97 %  94.36 %  91.19 %  88.02 %  81.82 %  75.90 %  90.06 %  98.03 %  98.17 % 
Accuracy  
(M1-6) 89.84 %  89.52 %  89.20 %  88.95 %  86.43 %  84.66 %  80.24 %  75.44 %  84.85 %  89.33 %  89.65 % 
Matthews 
Correlation 
Coefficient 0.27 0.27 0.3 0.36 0.34 0.34 0.31 0.3 0.3 0.31 0.32 
MCC 
(L, I, C, IC) 0.29 0.27 0.32 0.33  0.33  0.32  0.26  0.27  0.33  0.39  0.39 
MCC 
(M1-6) 0.26  0.26  0.27  0.38  0.34  0.36  0.35 
 0.32 
 0.27  0.22  0.25 
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Table 2: Summary statistics with CI and t-values and p-values for e-ASPECTS #OP4 and 
#OP5.  
 
 Difference in 
sensitivities  
95% CI Difference in 
specificities  
95% CI T statistic for 
non-
inferiority 
P-value for 
non-
inferiority 
OP#4 - 
NRAD#1 
-0.0165 
 
(-0.0765, 
0.0435) 
0.0385 
 
(0.0228, 
0.0542) 
-2.72 0.003 
GEE -0.0263 
 
(-0.1235, 
0.0710) 
0.0380 
 
(0.0180, 
0.0581) 
  
OP#4 - 
NRAD#2 
0.1683  
 
(0.1120, 
0.2246) 
-0.0389 
 
(-0.0515, -
0.0264) 
-8.19 <0.001 
GEE 0.1629 
 
(0.0762, 
0.2397) 
-0.0391 
 
(-0.0560, -
0.0222) 
  
OP#4 - 
NRAD#3 
0.1749175 
 
(0.1165, 
0.2334) 
-0.0445  
 
(-0.0560, -
0.0330) 
-8.05 <0.001 
GEE 0.1679 
 
(0.0831, 
0.2527) 
-0.0443 
 
(-0.0609, -
0.0276) 
  
OP#5 - 
NRAD#1 
0 
 
(-0.0624, 
0.0624) 
0.0197 
 
(0.0024, 
0.0370) 
-3.29 <0.001 
GEE -0.0078 
 
(-0.1056, 
0.0901) 
0.0195 
 
(-0.0016, 
0.0405) 
  
OP5# - 
NRAD#2 
0.1848  
 
(0.1251, 
0.2445) 
-0.0578 
 
(-0.0717, -
0.0439) 
-5.99 <0.001 
GEE 0.1810 
 
(0.0937, 
0.2682) 
-0.0575 
 
(-0.0756, -
0.0394) 
  
OP#5 - 
NRAD#3 
0.1914  
 
(0.1312, 
0.2516) 
-0.0633 
 
(-0.0760, -
0.0507) 
 -5.41 <0.001 
GEE 0.1859 
 
(0.1007, 
0.2712) 
-0.0627 
 
(-0.0806, -
0.0448) 
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